Egnyte Releases Quality Document Management Offering
Egnyte announced a new product for emerging life sciences companies to manage regulated documentation. Egnyte for Life Sciences Quality is a GxP-compliant product that digitizes the lifecycle of regulated documents, like standard operating procedures (SOPs) and training records. Egnyte for Life Sciences Quality is the third product in a growing lineup of offerings, following the release of Egnyte for Life Sciences in November 2020 and new review and approval workflows.
Egnyte for Life Sciences Quality enables Life Sciences companies to:
- Meet GxP & FDA 21 CFR Part 11
- Perform e-Signatures: sign off on documents, like SOPs and clinical trial protocols, in a compliant manner, without needing third-party plugins.
- Manage effective documents: as new versions are approved, Quality teams can define version numbers for new drafts, set expiry dates, and ensure only effective copies are available.
- Scale compliance processes quickly: built with best practices gleaned from 17,000 global customers, Egnyte for Life Sciences Quality implements and validates as it integrates with existing IT infrastructure.
- Support for multiple departments and use cases: designed with the ability to support training, continuity, and site readiness documentation.
For more information, click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
